[1]
|
Zhao, D., Liu, J., Wang, M., Zhang, X. and Zhou, M. (2018) Epidemiology of Cardiovascular Disease in China: Current Features and Implications. Nature Reviews Cardiology, 16, 203-212. https://doi.org/10.1038/s41569-018-0119-4
|
[2]
|
Fukumoto, Y. (2022) Lifestyle Intervention for Primary Prevention of Cardiovascular Diseases. European Journal of Preventive Cardiology, 29, 2250-2251. https://doi.org/10.1093/eurjpc/zwac245
|
[3]
|
Gossage, J.R. (1994) Acute Myocardial Infarction. Chest, 106, 1851-1866. https://doi.org/10.1378/chest.106.6.1851
|
[4]
|
Ali, Z.A., Horst, J., Gaba, P., Shaw, L.J., Bangalore, S., Hochman, J.S., et al. (2021) Standardizing the Definition and Analysis Methodology for Complete Coronary Artery Revascularization. Journal of the American Heart Association, 10, e020110. https://doi.org/10.1161/jaha.120.020110
|
[5]
|
Goldstein, J.A., Demetriou, D., Grines, C.L., Pica, M., Shoukfeh, M. and O’Neill, W.W. (2000) Multiple Complex Coronary Plaques in Patients with Acute Myocardial Infarction. New England Journal of Medicine, 343, 915-922. https://doi.org/10.1056/nejm200009283431303
|
[6]
|
Ibanez, B., James, S., Agewall, S., et al. (2018) 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation. European Heart Journal, 39, 119-177.
|
[7]
|
Park, D., Clare, R.M., Schulte, P.J., Pieper, K.S., Shaw, L.K., Califf, R.M., et al. (2014) Extent, Location, and Clinical Significance of Non-Infarct-Related Coronary Artery Disease among Patients with ST-Elevation Myocardial Infarction. JAMA, 312, 2019-2027. https://doi.org/10.1001/jama.2014.15095
|
[8]
|
Sorajja, P., Gersh, B.J., Cox, D.A., McLaughlin, M.G., Zimetbaum, P., Costantini, C., et al. (2007) Impact of Multivessel Disease on Reperfusion Success and Clinical Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction. European Heart Journal, 28, 1709-1716. https://doi.org/10.1093/eurheartj/ehm184
|
[9]
|
Kim, D.H., Burton, J.R., Fu, Y., Lindholm, L., Van de Werf, F. and Armstrong, P.W. (2006) What Is the Frequency and Functional and Clinical Significance of Complex Lesions in Non-Infarct-Related Arteries after Fibrinolysis for Acute ST-Elevation Myocardial Infarction? American Heart Journal, 151, 668-673. https://doi.org/10.1016/j.ahj.2005.05.006
|
[10]
|
Gershlick, A.H., Banning, A.S., Parker, E., Wang, D., Budgeon, C.A., Kelly, D.J., et al. (2019) Long-Term Follow-Up of Complete versus Lesion-Only Revascularization in STEMI and Multivessel Disease. Journal of the American College of Cardiology, 74, 3083-3094. https://doi.org/10.1016/j.jacc.2019.10.033
|
[11]
|
Engstrøm, T., Kelbæk, H., Helqvist, S., Høfsten, D.E., Kløvgaard, L., Holmvang, L., et al. (2015) Complete Revascularisation versus Treatment of the Culprit Lesion Only in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease (DANAMI-3—PRIMULTI): An Open-Label, Randomised Controlled Trial. The Lancet, 386, 665-671. https://doi.org/10.1016/s0140-6736(15)60648-1
|
[12]
|
Lønborg, J., Engstrøm, T., Kelbæk, H., Helqvist, S., Kløvgaard, L., Holmvang, L., et al. (2017) Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients with ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients with ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization). Circulation: Cardiovascular Interventions, 10, e004460. https://doi.org/10.1161/circinterventions.116.004460
|
[13]
|
Smits, P.C., Abdel-Wahab, M., Neumann, F., Boxma-de Klerk, B.M., Lunde, K., Schotborgh, C.E., et al. (2017) Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. New England Journal of Medicine, 376, 1234-1244. https://doi.org/10.1056/nejmoa1701067
|
[14]
|
Dambrink, J., Debrauwere, J., van‘t Hof, A., Ottervanger, J., Gosselink, A.T., Hoorntje, J., et al. (2010) Non-Culprit Lesions Detected during Primary PCI: Treat Invasively or Follow the Guidelines? EuroIntervention, 5, 968-975. https://doi.org/10.4244/eijv5i8a162
|
[15]
|
Cubero-Gallego, H., Romaguera, R., Ariza-Sole, A., Gómez-Hospital, J.A. and Cequier, A. (2017) Revascularization Strategies in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: Urgent or Staged? Cardiovascular Diagnosis and Therapy, 7, S82-S85. https://doi.org/10.21037/cdt.2017.01.15
|
[16]
|
Marenzi, G., Assanelli, E., Campodonico, J., Lauri, G., Marana, I., De Metrio, M., et al. (2009) Contrast Volume during Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality. Annals of Internal Medicine, 150, 170-177. https://doi.org/10.7326/0003-4819-150-3-200902030-00006
|
[17]
|
Bates, E.R., Tamis-Holland, J.E., Bittl, J.A., O’Gara, P.T. and Levine, G.N. (2016) PCI Strategies in Patients with ST Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease. Journal of the American College of Cardiology, 68, 1066-1081. https://doi.org/10.1016/j.jacc.2016.05.086
|
[18]
|
Heusch, G., Kleinbongard, P., Böse, D., Levkau, B., Haude, M., Schulz, R., et al. (2009) Coronary Microembolization: From Bedside to Bench and Back to Bedside. Circulation, 120, 1822-1836. https://doi.org/10.1161/circulationaha.109.888784
|
[19]
|
Hanratty, C.G., Koyama, Y., Rasmussen, H.H., Nelson, G.I.C., Hansen, P.S. and Ward, M.R. (2002) Exaggeration of Nonculprit Stenosis Severity during Acute Myocardial Infarction: Implications for Immediate Multivessel Revascularization. Journal of the American College of Cardiology, 40, 911-916. https://doi.org/10.1016/s0735-1097(02)02049-1
|
[20]
|
Kim, H.Y., Lim, H., Doh, J., Nam, C., Shin, E., Koo, B., et al. (2016) Physiological Severity of Coronary Artery Stenosis Depends on the Amount of Myocardial Mass Subtended by the Coronary Artery. JACC: Cardiovascular Interventions, 9, 1548-1560. https://doi.org/10.1016/j.jcin.2016.04.008
|
[21]
|
Kaski, J., Crea, F., Gersh, B.J. and Camici, P.G. (2018) Reappraisal of Ischemic Heart Disease. Circulation, 138, 1463-1480. https://doi.org/10.1161/circulationaha.118.031373
|
[22]
|
Bagai, A., Thavendiranathan, P., Sharieff, W., Al Lawati, H.A. and Cheema, A.N. (2013) Non-Infarct-Related Artery Revascularization during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis. American Heart Journal, 166, 684-693.e1. https://doi.org/10.1016/j.ahj.2013.07.027
|
[23]
|
Hannan, E.L., Samadashvili, Z., Walford, G., Holmes, D.R., Jacobs, A.K., Stamato, N.J., et al. (2010) Culprit Vessel Percutaneous Coronary Intervention versus Multivessel and Staged Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Patients with Multivessel Disease. JACC: Cardiovascular Interventions, 3, 22-31. https://doi.org/10.1016/j.jcin.2009.10.017
|
[24]
|
Jensen, L., Thayssen, P., Farkas, D., Hougaard, M., Terkelsen, C., Tilsted, H., et al. (2012) Culprit Only or Multivessel Percutaneous Coronary Interventions in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease. EuroIntervention, 8, 456-464. https://doi.org/10.4244/eijv8i4a72
|
[25]
|
Wald, D.S., Morris, J.K., Wald, N.J., Chase, A.J., Edwards, R.J., Hughes, L.O., et al. (2013) Randomized Trial of Preventive Angioplasty in Myocardial Infarction. New England Journal of Medicine, 369, 1115-1123. https://doi.org/10.1056/nejmoa1305520
|
[26]
|
Gershlick, A.H., Khan, J.N., Kelly, D.J., et al. (2015) Randomized Trial of Complete versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease: The CvLPRIT Trial. Journal of the American College of Cardiology, 65, 963-972.
|
[27]
|
Politi, L., Sgura, F., Rossi, R., Monopoli, D., Guerri, E., Leuzzi, C., et al. (2009) A Randomised Trial of Target-Vessel versus Multi-Vessel Revascularisation in ST-Elevation Myocardial Infarction: Major Adverse Cardiac Events during Long-Term Follow-Up. Heart, 96, 662-667. https://doi.org/10.1136/hrt.2009.177162
|
[28]
|
Levine, G.N., Bates, E.R., Blankenship, J.C., et al. (2016) 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation, 133, 1135-1147.
|
[29]
|
Wood, D.A., Cairns, J.A., Wang, J., et al. (2019) Timing of Staged Nonculprit Artery Revascularization in Patients with ST-Segment Elevation Myocardial Infarction: COMPLETE Trial. Journal of the American College of Cardiology, 74, 2713-2723.
|
[30]
|
Lawton, J.S., Tamis-Holland, J.E., Bangalore, S., Bates, E.R., Beckie, T.M., Bischoff, J.M., Bittl, J.A., et al. (2021) 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145, e4-e17. https://doi.org/10.1161/CIR.0000000000001061
|
[31]
|
Toma, M., Buller, C.E., Westerhout, C.M., Fu, Y., O’Neill, W.W., Holmes, D.R., et al. (2010) Non-Culprit Coronary Artery Percutaneous Coronary Intervention during Acute ST-Segment Elevation Myocardial Infarction: Insights from the APEX-AMI Trial. European Heart Journal, 31, 1701-1707. https://doi.org/10.1093/eurheartj/ehq129
|
[32]
|
Byrne, R.A., Rossello, X., Coughlan, J.J., et al. (2023) 2023 ESC Guidelines for the Management of Acute Coronary Syndromes. European Heart Journal, 44, 3720-3826
|
[33]
|
Diletti, R., den Dekker, W.K., Bennett, J., Schotborgh, C.E., van der Schaaf, R., Sabaté, M., et al. (2023) Immediate versus Staged Complete Revascularisation in Patients Presenting with Acute Coronary Syndrome and Multivessel Coronary Disease (BIOVASC): A Prospective, Open-Label, Non-Inferiority, Randomised Trial. The Lancet, 401, 1172-1182. https://doi.org/10.1016/s0140-6736(23)00351-3
|
[34]
|
Stähli, B.E., Varbella, F., Linke, A., Schwarz, B., Felix, S.B., Seiffert, M., et al. (2023) Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction. New England Journal of Medicine, 389, 1368-1379. https://doi.org/10.1056/nejmoa2307823
|
[35]
|
Elgendy, I.Y., Mahmoud, A.N., Kumbhani, D.J., Bhatt, D.L. and Bavry, A.A. (2017) Complete or Culprit-Only Revascularization for Patients with Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials. JACC: Cardiovascular Interventions, 10, 315-324. https://doi.org/10.1016/j.jcin.2016.11.047
|
[36]
|
Park, S., Rha, S., Choi, B.G., Cho, J.H., Park, S.H., Lee, J.B., et al. (2023) Immediate versus Staged Complete Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: Results from a Prematurely Discontinued Randomized Multicenter Trial. American Heart Journal, 259, 58-67. https://doi.org/10.1016/j.ahj.2023.01.020
|
[37]
|
Kornowski, R., Mehran, R., Dangas, G., Nikolsky, E., Assali, A., Claessen, B.E., et al. (2011) Prognostic Impact of Staged versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction: Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) Trial. Journal of the American College of Cardiology, 58, 704-711. https://doi.org/10.1016/j.jacc.2011.02.071
|
[38]
|
Doğan, C., Bayram, Z., Çap, M., Özkalaycı, F., Unkun, T., Erdoğan, E., et al. (2019) Comparison of 30-Day MACE between Immediate versus Staged Complete Revascularization in Acute Myocardial Infarction with Multivessel Disease, and the Effect of Coronary Lesion Complexity. Medicina, 55, Article 51. https://doi.org/10.3390/medicina55020051
|
[39]
|
Tarantini, G., D’Amico, G., Brener, S.J., Tellaroli, P., Basile, M., Schiavo, A., et al. (2016) Survival after Varying Revascularization Strategies in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis. JACC: Cardiovascular Interventions, 9, 1765-1776. https://doi.org/10.1016/j.jcin.2016.06.012
|
[40]
|
Vlaar, P.J., Mahmoud, K.D., Holmes, D.R., van Valkenhoef, G., Hillege, H.L., van der Horst, I.C.C., et al. (2011) Culprit Vessel Only versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting with ST-Segment Elevation Myocardial Infarction: A Pairwise and Network Meta-Analysis. Journal of the American College of Cardiology, 58, 692-703. https://doi.org/10.1016/j.jacc.2011.03.046
|
[41]
|
Di Mario, C. and Rosser, G. (2015) Open Questions for Non-Infarct-Related Arteries in STEMI. The Lancet, 386, 630-632. https://doi.org/10.1016/s0140-6736(15)60856-x
|
[42]
|
Iqbal, M.B., Nadra, I.J., Ding, L., Fung, A., Aymong, E., Chan, A.W., et al. (2017) Culprit Vessel versus Multivessel versus In-Hospital Staged Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease. JACC: Cardiovascular Interventions, 10, 11-23. https://doi.org/10.1016/j.jcin.2016.10.024
|
[43]
|
Wang, T.Y., Gutierrez, A. and Peterson, E.D. (2010) Percutaneous Coronary Intervention in the Elderly. Nature Reviews Cardiology, 8, 79-90. https://doi.org/10.1038/nrcardio.2010.184
|
[44]
|
Dodson, J.A., Hochman, J.S., Roe, M.T., Chen, A.Y., Chaudhry, S.I., Katz, S., et al. (2018) The Association of Frailty with In-Hospital Bleeding among Older Adults with Acute Myocardial Infarction. JACC: Cardiovascular Interventions, 11, 2287-2296. https://doi.org/10.1016/j.jcin.2018.08.028
|
[45]
|
Ono, M., Serruys, P.W., Hara, H., Kawashima, H., Gao, C., Wang, R., et al. (2021) 10-Year Follow-Up after Revascularization in Elderly Patients with Complex Coronary Artery Disease. Journal of the American College of Cardiology, 77, 2761-2773. https://doi.org/10.1016/j.jacc.2021.04.016
|
[46]
|
Newman, A.B., Naydeck, B.L., Sutton-Tyrrell, K., Feldman, A., Edmundowicz, D. and Kuller, L.H. (2001) Coronary Artery Calcification in Older Adults to Age 99: Prevalence and Risk Factors. Circulation, 104, 2679-2684. https://doi.org/10.1161/hc4601.099464
|
[47]
|
West, N.E.J., Ruygrok, P.N., Disco, C.M.C., Webster, M.W.I., Lindeboom, W.K., O’Neill, W.W., et al. (2004) Clinical and Angiographic Predictors of Restenosis after Stent Deployment in Diabetic Patients. Circulation, 109, 867-873. https://doi.org/10.1161/01.cir.0000116750.63158.94
|
[48]
|
Zhou, M., Liu, J., Hao, Y., Liu, J., Huo, Y., Smith, S.C., et al. (2018) Prevalence and In-Hospital Outcomes of Diabetes among Patients with Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Cardiovascular Diabetology, 17, Article No. 147. https://doi.org/10.1186/s12933-018-0793-x
|
[49]
|
Hannan, E.L., Zhong, Y., Berger, P.B., Jacobs, A.K., Walford, G., Ling, F.S.K., et al. (2018) Association of Coronary Vessel Characteristics with Outcome in Patients with Percutaneous Coronary Interventions with Incomplete Revascularization. JAMA Cardiology, 3, 123-130. https://doi.org/10.1001/jamacardio.2017.4787
|
[50]
|
Brener, S.J., Witzenbichler, B., Maehara, A., Dizon, J., Fahy, M., El-Omar, M., et al. (2013) Infarct Size and Mortality in Patients with Proximal versus Mid Left Anterior Descending Artery Occlusion: The Intracoronary Abciximab and Aspiration Thrombectomy in Patients with Large Anterior Myocardial Infarction (INFUSE-AMI) Trial. American Heart Journal, 166, 64-70. https://doi.org/10.1016/j.ahj.2013.03.029
|
[51]
|
Taniwaki, M., Stefanini, G.G., Räber, L., Brugaletta, S., Cequier, A., Heg, D., et al. (2015) Predictors of Adverse Events among Patients Undergoing Primary Percutaneous Coronary Intervention: Insights from a Pooled Analysis of the COMFORTABLE AMI and EXAMINATION Trials. EuroIntervention, 11, 391-398. https://doi.org/10.4244/eijy14m07_12
|
[52]
|
Lee, W., Chen, T., Chen, C., Yang, C., Fang, C., Wu, C., et al. (2020) The Effect of Complete Revascularization in Patients with ST-Segment Elevation Myocardial Infarction with Killip Class ≥ III. Coronary Artery Disease, 31, 13-19. https://doi.org/10.1097/mca.0000000000000815
|
[53]
|
Thiele, H., Akin, I., Sandri, M., Fuernau, G., de Waha, S., Meyer-Saraei, R., et al. (2017) PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. New England Journal of Medicine, 377, 2419-2432. https://doi.org/10.1056/nejmoa1710261
|
[54]
|
Thiele, H., Akin, I., Sandri, M., de Waha-Thiele, S., Meyer-Saraei, R., Fuernau, G., et al. (2018) One-Year Outcomes after PCI Strategies in Cardiogenic Shock. New England Journal of Medicine, 379, 1699-1710. https://doi.org/10.1056/nejmoa1808788
|
[55]
|
Scarsini, R., Shanmuganathan, M., Kotronias, R.A., Terentes-Printzios, D., Borlotti, A., Langrish, J.P., et al. (2021) Angiography-derived Index of Microcirculatory Resistance (Imrangio) as a Novel Pressure-Wire-Free Tool to Assess Coronary Microvascular Dysfunction in Acute Coronary Syndromes and Stable Coronary Artery Disease. The International Journal of Cardiovascular Imaging, 37, 1801-1813. https://doi.org/10.1007/s10554-021-02254-8
|
[56]
|
Vaidya, K., Tucker, B., Patel, S. and Ng, M.K.C. (2021) Acute Coronary Syndromes (ACS)—Unravelling Biology to Identify New Therapies—The Microcirculation as a Frontier for New Therapies in Acs. Cells, 10, Article 2188. https://doi.org/10.3390/cells10092188
|
[57]
|
Lee, P.H., Hong, S.J., Kim, H.S., et al. (2024) Quantitative Coronary Angiography vs Intravascular Ultrasonography to Guide Drug-Eluting Stent Implantation: A Randomized Clinical Trial. JAMA Cardiology, 9, 428-435.
|
[58]
|
Vijayvergiya, R., Kumar, B., Sahoo, S., Budhakoty, S. and Kasinadhuni, G. (2020) Optical Coherence Tomography Imaging in Acute Myocardial Infarction: Calcified Nodule as a Culprit Lesion. Journal of Invasive Cardiology, 32, E194-E195. https://doi.org/10.25270/jic/19.00412
|
[59]
|
Ruberti, A., Echevarría-Pinto, M. and Regueiro, A. (2024) Oct-guided versus IVUS-Guided Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction. Do We Have a Winner? Revista Española de Cardiología (English Edition), 77, 618-620. https://doi.org/10.1016/j.rec.2024.02.002
|
[60]
|
Li, X., Ge, Z., Kan, J., et al. (2024) Intravascular Ultrasound-Guided versus Angiography-Guided Percutaneous Coronary Intervention in Acute Coronary Syndromes (IVUS-ACS): A Two-Stage, Multicentre, Randomised Trial. Lancet, 403, 1855-1865.
|
[61]
|
Föllmer, B., Williams, M.C., Dey, D., Arbab-Zadeh, A., Maurovich-Horvat, P., Volleberg, R.H.J.A., et al. (2023) Roadmap on the Use of Artificial Intelligence for Imaging of Vulnerable Atherosclerotic Plaque in Coronary Arteries. Nature Reviews Cardiology, 21, 51-64. https://doi.org/10.1038/s41569-023-00900-3
|